– Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma multiforme (GBM) –
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- Florida Wildlife Corridor Foundation Celebrates 4-Year Anniversary of Landmark Corridor Act - July 1, 2025
- St. Peter Catholic Career and Technical High School Seeks Community Support to Empower Future Graduates - July 1, 2025
- Fred Meyer and Washington State Collaborate to Provide Free Locking Bags to Prevent Opioid Misuse - July 1, 2025
